Endometrial safety and efficacy of ospemifene

Menopause. 2023 Aug 1;30(8):788-790. doi: 10.1097/GME.0000000000002225. Epub 2023 Jul 18.
No abstract available

MeSH terms

  • Atrophy / pathology
  • Endometrium / pathology
  • Female
  • Humans
  • Selective Estrogen Receptor Modulators*
  • Tamoxifen* / adverse effects
  • Vagina / pathology
  • Vulva / pathology

Substances

  • Ospemifene
  • Tamoxifen
  • Selective Estrogen Receptor Modulators